Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 2/2009

01.04.2009 | Case Report

A case of anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor

verfasst von: Toru Murata, Masaki Terasaki, Kenji Sakaguchi, Masayuki Okubo, Yasuyuki Fukami, Kazumi Nishimae, Yasuhiko Kitayama, Shoji Hoshi

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

We report a case of anaplastic carcinoma of the pancreas with production of granulocyte-colony stimulating factor (G-CSF) in a 59-year-old male. He was referred to our hospital with a chief complaint of epigastralgia and suffered from leukocytosis. Differential diagnosis included pancreatic tumors and submucosal tumor of the stomach, but definite preoperative diagnosis could not be made. He underwent distal pancreactomy, total gastrectomy with Roux-en-Y reconstruction and splenectomy. He recovered uneventfully postoperatively and was discharged from hospital on the 14th postoperative day. Histological examination showed anaplastic carcinoma of the pancreas. Since the peripheral leukocyte count was sharply decreased after the operation, we suspected the tumor would be producing G-CSF. Then immunohistochemistry showed a positive stain in the tumor. Therefore, we diagnosed the tumor as anaplastic carcinoma of the pancreas producing G-CSF. Three months after the resection, local recurrence was detected by abdominal computed tomography. The patient died of hemorrhagic shock due to tumor invasion of the intestine 8 months after the operation.
Literatur
1.
Zurück zum Zitat Sommers SC, Meissner WA. Unusual carcinomas of the pancreas. Arch Pathol. 1954;58:101–11. Sommers SC, Meissner WA. Unusual carcinomas of the pancreas. Arch Pathol. 1954;58:101–11.
2.
Zurück zum Zitat Solcia E, Capella C, Kloppel G. Atlas of tumor pathology tumors of the pancreas. 3rd edn. Washington: Armed Forces Institute of Pathology; 1997. p. 92. Solcia E, Capella C, Kloppel G. Atlas of tumor pathology tumors of the pancreas. 3rd edn. Washington: Armed Forces Institute of Pathology; 1997. p. 92.
3.
Zurück zum Zitat Asano S, Urabe A. Demonstration of granulopoietic factors in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–51.PubMed Asano S, Urabe A. Demonstration of granulopoietic factors in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–51.PubMed
4.
Zurück zum Zitat Japan Pancreas Society. Classification of pancreatic carcinoma. Tokyo: Kanehara & Co; 1996. p. 35. Japan Pancreas Society. Classification of pancreatic carcinoma. Tokyo: Kanehara & Co; 1996. p. 35.
5.
Zurück zum Zitat Fahey RJ. Unusual leukocyte responses in primary carcinoma of the lung. Cancer. 1951;4:930–5.CrossRefPubMed Fahey RJ. Unusual leukocyte responses in primary carcinoma of the lung. Cancer. 1951;4:930–5.CrossRefPubMed
6.
Zurück zum Zitat Nakamura K, Takahashi T, Tsuyuoka R, Ueda Y, Suzuki A, Okuno Y, et al. Identification of colony-stimulating factor activity in patients with malignant tumors associated with excessive leukocytosis. Jpn J Clin Oncol. 1991;21:395–9.PubMed Nakamura K, Takahashi T, Tsuyuoka R, Ueda Y, Suzuki A, Okuno Y, et al. Identification of colony-stimulating factor activity in patients with malignant tumors associated with excessive leukocytosis. Jpn J Clin Oncol. 1991;21:395–9.PubMed
7.
Zurück zum Zitat Uematsu T, Tsuchie K, Ukai K, Kimoto E, Funakawa T, Mizuno R. Granulocyte-colony stimulating factor produced by pancreatic carcinoma. Int J Pancreatol. 1996;19:135–9.PubMed Uematsu T, Tsuchie K, Ukai K, Kimoto E, Funakawa T, Mizuno R. Granulocyte-colony stimulating factor produced by pancreatic carcinoma. Int J Pancreatol. 1996;19:135–9.PubMed
8.
Zurück zum Zitat Ohtsubo K, Mouri H, Sakai J, Akasofu M, Yamaguchi Y, Watanabe H, et al. Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry. J Clin Gastroenterol. 1998;27:357–60.CrossRefPubMed Ohtsubo K, Mouri H, Sakai J, Akasofu M, Yamaguchi Y, Watanabe H, et al. Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry. J Clin Gastroenterol. 1998;27:357–60.CrossRefPubMed
9.
Zurück zum Zitat Fukushima N, Sasatomi E, Tokunaga O, Miyahara M. A case of pancreatic cancer with production of granulocyte-colony stimulating factor. Am J Gastroenterol. 2001;96:258–9.CrossRefPubMed Fukushima N, Sasatomi E, Tokunaga O, Miyahara M. A case of pancreatic cancer with production of granulocyte-colony stimulating factor. Am J Gastroenterol. 2001;96:258–9.CrossRefPubMed
10.
Zurück zum Zitat Otani S, Hamazoe R, Shirai H, Sumi K, Murata Y, Kinugasa Y, et al. Granulocyte-colony stimulating factor producing pancreatic cancer confirmed by immunohistochemistry. Jpn J Cancer Clin. 2002;48:431–4. (Japanese with English abstract). Otani S, Hamazoe R, Shirai H, Sumi K, Murata Y, Kinugasa Y, et al. Granulocyte-colony stimulating factor producing pancreatic cancer confirmed by immunohistochemistry. Jpn J Cancer Clin. 2002;48:431–4. (Japanese with English abstract).
11.
Zurück zum Zitat Ando N, Fukuhara S, Mizuno Y, Ando H. A case of granulocyte-colony stimulating factor producing anaplastic ductal carcinoma of pancreas. Nihon Shokakigeka Gakkai Zasshi. 2005;38:318–23. (Japanese with English abstract). Ando N, Fukuhara S, Mizuno Y, Ando H. A case of granulocyte-colony stimulating factor producing anaplastic ductal carcinoma of pancreas. Nihon Shokakigeka Gakkai Zasshi. 2005;38:318–23. (Japanese with English abstract).
12.
Zurück zum Zitat Kobayashi H, Nozaki H, Shimizu M, Hidemura K, Tanaka C, Sassa M. A case of adenosquamous carcinoma of the pancreas producing granulocyte-colony stimulating factor. Nihon Rinshougeka Gakkaishi. 2005;66:707–11. (Japanese with English abstract). Kobayashi H, Nozaki H, Shimizu M, Hidemura K, Tanaka C, Sassa M. A case of adenosquamous carcinoma of the pancreas producing granulocyte-colony stimulating factor. Nihon Rinshougeka Gakkaishi. 2005;66:707–11. (Japanese with English abstract).
13.
Zurück zum Zitat Gotohda N, Nakagohri T, Saito N, Ono M, Sugito M, Ito M, et al. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepatogastroenterology. 2006;53:957–9.PubMed Gotohda N, Nakagohri T, Saito N, Ono M, Sugito M, Ito M, et al. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepatogastroenterology. 2006;53:957–9.PubMed
14.
Zurück zum Zitat Kawakami H, Kuwatani M, Fujiya Y, Uebayashi M, Konishi K, Makiyama H, et al. A case of granulocyte-colony stimulating factor producing ductal adenocarcinoma of the pancreas. Nippon Shokakibyo Gakkai Zasshi. 2007;104:233–8. (Japanese with English abstract).PubMed Kawakami H, Kuwatani M, Fujiya Y, Uebayashi M, Konishi K, Makiyama H, et al. A case of granulocyte-colony stimulating factor producing ductal adenocarcinoma of the pancreas. Nippon Shokakibyo Gakkai Zasshi. 2007;104:233–8. (Japanese with English abstract).PubMed
15.
Zurück zum Zitat Takami K, Miura K, Takeuchi H, Egawa S, Moriya T, Nakamura Y, et al. Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a case. Surg Today. 2008;38:453–7.CrossRefPubMed Takami K, Miura K, Takeuchi H, Egawa S, Moriya T, Nakamura Y, et al. Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a case. Surg Today. 2008;38:453–7.CrossRefPubMed
16.
Zurück zum Zitat Shimamura K, Fujimoto J, Hata J, Akatsuka A, Ueyama Y, Watanabe T, et al. Establishment of specific monoclonal antibodies against recombinant human granulocyte-colony stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections. J Histochem Cytochem. 1990;38:283–6.CrossRefPubMed Shimamura K, Fujimoto J, Hata J, Akatsuka A, Ueyama Y, Watanabe T, et al. Establishment of specific monoclonal antibodies against recombinant human granulocyte-colony stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections. J Histochem Cytochem. 1990;38:283–6.CrossRefPubMed
17.
Zurück zum Zitat Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res. 1995;55:3438–43.PubMed Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res. 1995;55:3438–43.PubMed
18.
Zurück zum Zitat Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage. 2000;20:214–32.CrossRefPubMed Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage. 2000;20:214–32.CrossRefPubMed
19.
Zurück zum Zitat Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage-colony stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer. 1999;79:40–6.CrossRefPubMedPubMedCentral Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage-colony stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer. 1999;79:40–6.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Groblewska M, Mroczko B, W-Siemiatkowska U, Mysliwiec P, Kedra B, Szmitkowski M. Serum levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med. 2007;45:30–4.CrossRefPubMed Groblewska M, Mroczko B, W-Siemiatkowska U, Mysliwiec P, Kedra B, Szmitkowski M. Serum levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med. 2007;45:30–4.CrossRefPubMed
21.
Zurück zum Zitat Yamaguchi K, Nakamura K, Shimizu S, Yokohata K, Morisaki T, Chijiwa K, et al. Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection. Am J Gastroenterol. 1998;93:1151–5.CrossRefPubMed Yamaguchi K, Nakamura K, Shimizu S, Yokohata K, Morisaki T, Chijiwa K, et al. Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection. Am J Gastroenterol. 1998;93:1151–5.CrossRefPubMed
22.
Zurück zum Zitat Saegusa S, Sekoguchi T, Kuriyama N, Ido M, Ito F, Yamazaki Y. Anaplastic ductal carcinoma of the pancreas with more than 10-year postoperative survival. Report of 3 cases. Suizou. 2005;20:46–54. (Japanese with English abstract).CrossRef Saegusa S, Sekoguchi T, Kuriyama N, Ido M, Ito F, Yamazaki Y. Anaplastic ductal carcinoma of the pancreas with more than 10-year postoperative survival. Report of 3 cases. Suizou. 2005;20:46–54. (Japanese with English abstract).CrossRef
23.
Zurück zum Zitat Tsujie M, Nakamori S, Nakazuru S, Hayashi N, Okami J, Nagano H, et al. A case of liver metastasis of pancreatic duct carcinoma successfully treated with Gemcitabine. Jpn J Cancer Chemother. 2003;30:297–301. (Japanese with English abstract). Tsujie M, Nakamori S, Nakazuru S, Hayashi N, Okami J, Nagano H, et al. A case of liver metastasis of pancreatic duct carcinoma successfully treated with Gemcitabine. Jpn J Cancer Chemother. 2003;30:297–301. (Japanese with English abstract).
Metadaten
Titel
A case of anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor
verfasst von
Toru Murata
Masaki Terasaki
Kenji Sakaguchi
Masayuki Okubo
Yasuyuki Fukami
Kazumi Nishimae
Yasuhiko Kitayama
Shoji Hoshi
Publikationsdatum
01.04.2009
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 2/2009
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-008-0058-4

Weitere Artikel der Ausgabe 2/2009

Clinical Journal of Gastroenterology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.